Occult hepatitis B virus infection with low viremia induces DNA damage, apoptosis and oxidative stress in peripheral blood lymphocytes

Virus Research

Volumn 153, Issue 1, 2010, Pages 143-150

  Bhargava, Arpit ^a,b   Khan, Saba ^a   Panwar, Hariom ^a   Pathak, Neelam ^a   Punde, Ram P ^a   Varshney, Subodh ^a   Mishra, Pradyumna K ^a,b  

^a BHOPAL MEMORIAL HOSPITAL AND RESEARCH CENTRE   (India)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

Circulating nucleosomes; DNA damage response; Hepatitis; Occult infections; Oxidative stress

Indexed keywords

ATM PROTEIN; ATR PROTEIN; HISTONE H2AX; PROTEIN P53;

ADULT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; NUCLEOSOME; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VIREMIA; VIRUS CELL INTERACTION;

ADULT; APOPTOSIS; BLOOD CHEMICAL ANALYSIS; DNA DAMAGE; DNA FRAGMENTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LYMPHOCYTES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MIDDLE AGED; NUCLEOSOMES; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; VIREMIA;

HEPATITIS B VIRUS;

EID: 77956228696     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.07.023     Document Type: Article

References (52)

1. Bakkenist C.J., Kastan M.B. Initiating cellular stress responses. Cell 2004, 118:9-17.
2. Bartek J., Lukas J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr. Opin. Cell Biol. 2001, 13:738-747.
3. Baumert T.F., Thimme R., von Weizsäcker F. Pathogenesis of hepatitis B virus infection. World J. Gastroenterol. 2007, 13:82-90.
4. Bertoletti A., Gehring A.J. The immune response during hepatitis B virus infection. J. Gen. Virol. 2006, 87:1439-1449.
5. Bolukbas C., Bolukbas F.F., Kocyigit A., Aslan M., Selek S., Bitiren M., Ulukanligil M. Relationship between levels of DNA damage in lymphocytes and histopathological severity of chronic hepatitis C and various clinical forms of hepatitis B. J. Gastroenterol. Hepatol. 2006, 21:610-616.
6. Brown E.J., Baltimore D. Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev. 2003, 17:615-628.
7. Canakci C.F., Cicek Y., Canacki V. Reactive oxygen species and human inflammatory periodontal diseases. Biochemistry (Mosc) 2005, 70:619-628.
8. Collins A.R., Duthie S.J., Fillion L., Gedik C.M., Vaughan N., Wood S.G. Oxidative DNA damage in human cells: the influence of antioxidants and DNA repair. Biochem. Soc. Trans. 1997, 25:326-331.
9. Derheimer F.A., O'Hagan H.M., Krueger H.M., Hanasoge S., Paulsen M.T., Ljungman M. RPA and ATR link transcriptional stress to p53. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12778-12783.
10. Gaspar M., Shenk T. Human cytomegalovirus inhibits a DNA damage response by mislocalizing checkpoint proteins. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2821-2826.
11. Giaccia A.J., Kastan M.B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 1998, 12:2973-2983.
12. Hou J., Wang Z., Cheng J., Lin Y., Lau G.K., Sun J., Zhou F., Waters J., Karayiannis P., Luo K. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 2001, 34:1027-1034.
13. Hu K.Q. Occult hepatitis B virus infection and its clinical implications. J. Viral Hepat. 2002, 9:243-257.
14. Khettry U., Anand N., Gordon F.D., Jenkins R.L., Tahan S.R., Loda M., Lewis W.D. Recurrent hepatitis B, hepatitis C, and combined hepatitis B and C in liver allografts: a comparative pathological study. Hum. Pathol. 2000, 31:101-108.
15. Kim H.J., Kim S.Y., Kim J., Lee H., Choi M., Kim J.K., Ahn J.K. Hepatitis B virus X protein induces apoptosis by enhancing translocation of Bax to mitochondria. IUBMB Life 2008, 60:473-480.
16. Kremer A.E., Rust C., Eichhorn P., Beuers U., Holdenrieder S. Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers. Expert Rev. Mol. Diagn. 2009, 9:139-156.
17. Kudoh A., Fujita M., Zhang L., Shirata N., Daikoku T., Sugaya Y., Isomura H., Nishiyama Y., Tsurumi T. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J. Biol. Chem. 2005, 280:8156-8163.
18. Kuo L.J., Yang L.X. Gamma-H2AX-a novel biomarker for DNA double-strand breaks. In Vivo 2008, 22:305-309.
19. Lai C.L., Yuen M.F. The natural history of chronic hepatitis B. J. Viral Hepat. 2007, 14:6-10.
20. Lau J.Y., Xie X., Lai M.M., Wu P.C. Apoptosis and viral hepatitis. Semin. Liver Dis. 1998, 18:169-176.
21. Liang X., Pickering M.T., Cho N.H., Chang H., Volkert M.R., Kowalik T.F., Jung J.U. Deregulation of DNA damage signal transduction by herpesvirus latency-associated M2. J. Virol. 2006, 80:5862-5874.
22. Lilley C.E., Schwartz R.A., Weitzman M.D. Using or abusing: viruses and the cellular DNA damage response. Trends Microbiol. 2007, 15:119-126.
23. Liu D.X. A new hypothesis of pathogenetic mechanism of viral hepatitis B and C. Med. Hypotheses 2001, 56:405-408.
24. Liu J., Shen H.M., Ong C.N. Role of intracellular thiol depletion, mitochondrial dysfunction and reactive oxygen species in Salvia miltiorrhiza-induced apoptosis in human hepatoma HepG2 cells. Life Sci. 2001, 69:1833-1850.
25. Liu Y., Wang K., Wang J.F. Hepatocyte apoptosis in the patients with chronic hepatitis B. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2008, 22:425-427.
26. Ljungman M., Lane D.P. Transcription-guarding the genome by sensing DNA damage. Nat. Rev. Cancer 2004, 4:727-737.
27. Martin-Lluesma S., Schaeffer C., Robert E.I., van Breugel P.C., Leupin O., Hantz O., Strubin M. Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1. Hepatology 2008, 48:1467-1476.
28. Michalak T.I., Hodgson P.D., Churchill N.D. Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection. J. Virol. 2000, 74:4483-4494.
29. Mishra P.K., Panwar H., Bhargava A., Gorantla V.R., Jain S.K., Banerjee S., Maudar K.K. Isocyanates induces DNA damage, apoptosis, oxidative stress and inflammation in cultured human lymphocytes. J. Biochem. Mol. Toxicol. 2008, 22:429-440.
30. Mishra P.K., Raghuram G.V., Panwar H., Jain D., Pandey H., Maudar K.K. Mitochondrial oxidative stress elicits chromosomal instability after exposure to isocyanates in human kidney epithelial cells. Free Radic. Res. 2009, 43:718-728.
31. Mishra P.K., Khan S., Bhargava A., Panwar H., Banerjee S., Jain S.K., Maudar K.K. Regulation of isocyanate-induced apoptosis, oxidative stress, and inflammation in cultured human neutrophils: isocyanate-induced neutrophils apoptosis. Cell Biol. Toxicol. 2010, 26:279-291.
32. Murakami Y., Minami M., Daimon Y., Okanoue T. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen. J. Med. Virol. 2004, 72:203-214.
33. Ozkal P., Ilgin-Ruhi H., Akdogan M., Elhan A.H., Kaçar S., Sasmaz N. The genotoxic effects of hepatitis B virus to host DNA. Mutagenesis 2005, 20:147-150.
34. Pawlak K., Pawlak D., Mysliwiec M. Hepatitis intensified oxidative stress. MIP-1beta and RANTES plasma levels in uraemic patients. Cytokine 2004, 28:197-204.
35. Pontisso P., Vidalino L., Quarta S., Gatta A. Biological and clinical implications of HBV infection in peripheral blood mononuclear cells. Autoimmun. Rev. 2008, 8:13-17.
36. Raimondo G., Allain J.P., Brunetto M.R., Buendia M.A., Chen D.S., Colombo M., Craxì A., Donato F., Ferrari C., Gaeta G.B., Gerlich W.H., Levrero M., Locarnini S., Michalak T., Mondelli M.U., Pawlotsky J.M., Pollicino T., Prati D., Puoti M., Samuel D., Shouval D., Smedile A., Squadrito G., Trépo C., Villa E., Will H., Zanetti A.R., Zoulim F. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J. Hepatol. 2008, 49:652-657.
37. Sagnelli E., Imparato M., Coppola N., Pisapia R., Sagnelli C., Messina V., Piai G., Stanzione M., Bruno M., Moggio G., Caprio N., Pasquale G., Del Vecchio Blanco C. Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study. J. Med. Virol. 2008, 80:1547-1553.
38. Sancar A., Lindsey-Boltz L.A., Unsal-Kacmaz K., Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 2004, 73:39-85.
39. Severi T., Ying C., Vermeesch J.R., Cassiman D., Cnops L., Verslype C., Fevery J., Arckens L., Neyts J., van Pelt J.F. Hepatitis B virus replication causes oxidative stress in HepAD38 liver cells. Mol. Cell. Biochem. 2006, 290:79-85.
40. Severi T., Vander Borght S., Libbrecht L., VanAelst L., Nevens F., Roskams T., Cassiman D., Fevery J., Verslype C., van Pelt J.F. HBx or HCV core gene expression in HepG2 human liver cells results in a survival benefit against oxidative stress with possible implications for HCC development. Chem. Biol. Interact. 2007, 168:128-134.
41. Sinclair A., Yarranton S., Schelcher C. DNA-damage response pathways triggered by viral replication. Expert Rev. Mol. Med. 2006, 8:1-11.
42. Stoll-Becker S., Repp R., Glebe D., Schaefer S., Kreuder J., Kann M., Lampert F., Gerlich W.H. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J. Virol. 1997, 71:5399-5407.
43. Stracker T.H., Carson C.T., Weitzman M.D. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 2002, 418:348-352.
44. Tamori A., Nishiguchi S., Kubo S., Narimatsu T., Habu D., Takeda T., Hirohashi K., Shiomi S. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. J. Med. Virol. 2003, 71:492-498.
45. Uziel T., Lerenthal Y., Moyal L., Andegeko Y., Mittelman L., Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 2003, 22:5612-5621.
46. Wang K., Wang B., Fan X.P., Lin Y.J., Shui W.P. Oxidative stress in patients with chronic hepatitis B. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2004, 18:172-174.
47. Wang W.H., Hullinger R.L., Andrisani O.M. Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis. J. Biol. Chem. 2008, 283:25455-25467.
48. Waris G., Siddiqui A. Regulatory mechanisms of viral hepatitis B and C. J. Biosci. 2003, 28:311-321.
49. World Health Organization, August 2008. Fact Sheet No. 204. http://www.who.int/media%20centre/factsheets/fs204/en/index.html.
50. Wright T.L. Introduction to chronic hepatitis B infection. Am. J. Gastroenterol. 2006, 101:S1-S6.
51. Zhao F., Hou N.B., Song T., He X., Zheng Z.R., Ma Q.J., Li L., Zhang Y.H., Zhong H. Cellular DNA repair cofactors affecting hepatitis B virus infection and replication. World J. Gastroenterol. 2008, 14:5059-5065.
52. Zhao F., Hou N.B., Yang X.L., He X., Liu Y., Zhang Y.H., Wei C.W., Song T., Li L., Ma Q.J., Zhong H. Ataxia telangiectasia-mutated-Rad3-related DNA damage checkpoint signaling pathway triggered by hepatitis B virus infection. World J. Gastroenterol. 2008, 14:6163-6170.